ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain

ClinicalTrials.gov ID: NCT00312195

Public ClinicalTrials.gov record NCT00312195. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 3:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Run-in, Followed by a Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Show the Effectiveness of Buprenorphine Transdermal System in Management of Patients With Chronic Nonmalignant Pain Syndromes

Study identification

NCT ID
NCT00312195
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
267 participants

Conditions and interventions

Interventions

  • Buprenorphine transdermal patch Drug
  • Placebo to match BTDS Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2001
Primary completion
Jun 30, 2001
Completion
Jun 30, 2001
Last update posted
Sep 9, 2012

2001

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
Hawthorne and York Phoenix Arizona 85008
Arizona Research Center Inc Phoenix Arizona 85023
Clinical Research Consultants Inc Trumbull Connecticut 06611
Tampa Bay Medical Research Inc Clearwater Florida 33761
Clinical Research of South Florida Coral Gables Florida 33134
University Clinical Research Deland DeLand Florida 32702
University Clinical Research Inc, Pembroke Pines Florida 33024
Gold Coast Research LLC Plantation Florida 33324
Gold Coast Research LLC Tamarac Florida 33321
Family Medicine Associates Evansville Indiana 47712
Pain Management and Rehabilitation Terre Haute Indiana 47802
Southeastern Center for Headache and Pain Crestview Heights Kentucky 41017
Westside Family Medical Center PC Kalamazoo Michigan 49009
The Arthritis Clinic Charlotte North Carolina 28211
Cornerstone Research Care High Point North Carolina 27262
ALL-TRIALS Clinical Research LLC Winston-Salem North Carolina 27103
Private Practice Chardon Ohio 44024
Summit Research Solutions Memphis Tennessee 38119
Radiant Research Austin Texas 78758
Wasatch Clinical Research Salt Lake City Utah 84107
Clinical Research Management New Berlin Wisconsin 53151

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00312195, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2012 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00312195 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →